Raymed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 ,inter alia, to consider and approve Plese find the attached Intimation ....
Awaiting price reaction for this filing.
Cresanto Global Ltd has called a board meeting on 1 August 2025 to consider several key items. The most notable is a proposal to reduce the company's share capital under Section 66 of the Companies Act, 2013, which will need approval from shareholders and the National Company Law Tribunal (NCLT). The board will also appoint M/s. Nidhi Bajaj & Associates as Secretarial Auditor for a five-year term and Ms. Komal Bajaj as Internal Auditor for FY2025-26. Additionally, they will approve the Board's Report for FY2024-25 and decide the date, time, and venue for the upcoming Annual General Meeting, along with fixing the book closure date. The company was formerly known as Raymed Labs Limited.
The proposed share capital reduction is a significant event that could change the company's capital structure and affect existing shareholders, pending NCLT and shareholder approvals. The outcome of the 1 August board meeting will be closely watched by investors for confirmation of the reduction terms and AGM schedule.